Research programme: cognitive disorders therapeutics - Cenomed BioSciencesAlternative Names: CB-2,433; CM-2,433; CM-2,450
Latest Information Update: 02 Jul 2010
At a glance
- Originator Medical College of Georgia
- Class Small molecules
- Mechanism of Action Cholinergic receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Alzheimer's disease; Mild cognitive impairment